This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n8http://linked.opendata.cz/resource/drugbank/drug/DB04031/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04031/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04031/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04031/identifier/pdb/

Statements

Subject Item
n2:DB04031
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04031 n13:DB04031
dcterms:title
Serine Vanadate
adms:identifier
n8:17754186 n9:46506158 n10:DB04031 n12:SVA
n3:synonym
SVA
n3:IUPAC-Name
n4:271B5A5A-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5A60-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5A5F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5A5C-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5A5D-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5A5E-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5A58-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5A56-363D-11E5-9242-09173F13E4C5 n4:271B5A59-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5A57-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5A66-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5A67-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5A61-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5A62-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5A64-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5A63-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5A65-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5A6C-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5A6E-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5A6F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5A6B-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5A6A-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5A6D-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5A5B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5A68-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5A69-363D-11E5-9242-09173F13E4C5